174 related articles for article (PubMed ID: 24069415)
21. Inhibition of Src family kinases with dasatinib blocks migration and invasion of human melanoma cells.
Buettner R; Mesa T; Vultur A; Lee F; Jove R
Mol Cancer Res; 2008 Nov; 6(11):1766-74. PubMed ID: 19010823
[TBL] [Abstract][Full Text] [Related]
22. C-terminal Src kinase-mediated EPIYA phosphorylation of Pragmin creates a feed-forward C-terminal Src kinase activation loop that promotes cell motility.
Senda Y; Murata-Kamiya N; Hatakeyama M
Cancer Sci; 2016 Jul; 107(7):972-80. PubMed ID: 27116701
[TBL] [Abstract][Full Text] [Related]
23. SRC signaling is crucial in the growth of synovial sarcoma cells.
Michels S; Trautmann M; Sievers E; Kindler D; Huss S; Renner M; Friedrichs N; Kirfel J; Steiner S; Endl E; Wurst P; Heukamp L; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Cancer Res; 2013 Apr; 73(8):2518-28. PubMed ID: 23580575
[TBL] [Abstract][Full Text] [Related]
24. Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes.
González-Sánchez A; Jaraíz-Rodríguez M; Domínguez-Prieto M; Herrero-González S; Medina JM; Tabernero A
Oncotarget; 2016 Aug; 7(31):49819-49833. PubMed ID: 27391443
[TBL] [Abstract][Full Text] [Related]
25. Src family kinases differentially influence glioma growth and motility.
Lewis-Tuffin LJ; Feathers R; Hari P; Durand N; Li Z; Rodriguez FJ; Bakken K; Carlson B; Schroeder M; Sarkaria JN; Anastasiadis PZ
Mol Oncol; 2015 Nov; 9(9):1783-98. PubMed ID: 26105207
[TBL] [Abstract][Full Text] [Related]
26. UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer.
Gilani RA; Phadke S; Bao LW; Lachacz EJ; Dziubinski ML; Brandvold KR; Steffey ME; Kwarcinski FE; Graveel CR; Kidwell KM; Merajver SD; Soellner MB
Clin Cancer Res; 2016 Oct; 22(20):5087-5096. PubMed ID: 27154914
[TBL] [Abstract][Full Text] [Related]
27. A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK.
Jaraíz-Rodríguez M; Tabernero MD; González-Tablas M; Otero A; Orfao A; Medina JM; Tabernero A
Stem Cell Reports; 2017 Aug; 9(2):451-463. PubMed ID: 28712848
[TBL] [Abstract][Full Text] [Related]
28. Growth-arrest-specific 7C protein inhibits tumor metastasis via the N-WASP/FAK/F-actin and hnRNP U/β-TrCP/β-catenin pathways in lung cancer.
Tseng RC; Chang JW; Mao JS; Tsai CD; Wu PC; Lin CJ; Lu YL; Liao SY; Cheng HC; Hsu HS; Wang YC
Oncotarget; 2015 Dec; 6(42):44207-21. PubMed ID: 26506240
[TBL] [Abstract][Full Text] [Related]
29. Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer.
Wheeler SE; Morariu EM; Bednash JS; Otte CG; Seethala RR; Chiosea SI; Grandis JR
Clin Cancer Res; 2012 May; 18(10):2850-60. PubMed ID: 22490227
[TBL] [Abstract][Full Text] [Related]
30. TRPV4 activates the Cdc42/N-wasp pathway to promote glioblastoma invasion by altering cellular protrusions.
Yang W; Wu PF; Ma JX; Liao MJ; Xu LS; Yi L
Sci Rep; 2020 Aug; 10(1):14151. PubMed ID: 32843668
[TBL] [Abstract][Full Text] [Related]
31. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.
Hiscox S; Morgan L; Green TP; Barrow D; Gee J; Nicholson RI
Breast Cancer Res Treat; 2006 Jun; 97(3):263-74. PubMed ID: 16333527
[TBL] [Abstract][Full Text] [Related]
32. Cdc42 regulates Fc gamma receptor-mediated phagocytosis through the activation and phosphorylation of Wiskott-Aldrich syndrome protein (WASP) and neural-WASP.
Park H; Cox D
Mol Biol Cell; 2009 Nov; 20(21):4500-8. PubMed ID: 19741094
[TBL] [Abstract][Full Text] [Related]
33. Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib.
Serrels A; Macpherson IR; Evans TR; Lee FY; Clark EA; Sansom OJ; Ashton GH; Frame MC; Brunton VG
Mol Cancer Ther; 2006 Dec; 5(12):3014-22. PubMed ID: 17148760
[TBL] [Abstract][Full Text] [Related]
34. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.
Lu KV; Zhu S; Cvrljevic A; Huang TT; Sarkaria S; Ahkavan D; Dang J; Dinca EB; Plaisier SB; Oderberg I; Lee Y; Chen Z; Caldwell JS; Xie Y; Loo JA; Seligson D; Chakravari A; Lee FY; Weinmann R; Cloughesy TF; Nelson SF; Bergers G; Graeber T; Furnari FB; James CD; Cavenee WK; Johns TG; Mischel PS
Cancer Res; 2009 Sep; 69(17):6889-98. PubMed ID: 19690143
[TBL] [Abstract][Full Text] [Related]
35. Loss of Scar/WAVE complex promotes N-WASP- and FAK-dependent invasion.
Tang H; Li A; Bi J; Veltman DM; Zech T; Spence HJ; Yu X; Timpson P; Insall RH; Frame MC; Machesky LM
Curr Biol; 2013 Jan; 23(2):107-17. PubMed ID: 23273897
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of a Wiscott-Aldrich syndrome protein-associated signal complex is critical in osteoclast bone resorption.
Chellaiah MA; Kuppuswamy D; Lasky L; Linder S
J Biol Chem; 2007 Mar; 282(13):10104-10116. PubMed ID: 17283076
[TBL] [Abstract][Full Text] [Related]
37. Repetitive deformation activates Src-independent FAK-dependent ERK motogenic signals in human Caco-2 intestinal epithelial cells.
Chaturvedi LS; Gayer CP; Marsh HM; Basson MD
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1350-61. PubMed ID: 18400991
[TBL] [Abstract][Full Text] [Related]
38. SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells.
Vultur A; Buettner R; Kowolik C; Liang W; Smith D; Boschelli F; Jove R
Mol Cancer Ther; 2008 May; 7(5):1185-94. PubMed ID: 18483306
[TBL] [Abstract][Full Text] [Related]
39. Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases.
Banin S; Truong O; Katz DR; Waterfield MD; Brickell PM; Gout I
Curr Biol; 1996 Aug; 6(8):981-8. PubMed ID: 8805332
[TBL] [Abstract][Full Text] [Related]
40. Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.
Gomes EG; Connelly SF; Summy JM
Pancreas; 2013 Jul; 42(5):795-806. PubMed ID: 23271399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
